Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
This is a case report of a 68-year-old man with hepatocellular carcinoma (HCC) accompanied by hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, and hepatic vascular malformation. HHT is an autosomal dominant disorder of the fibrovascular tissue that is characterized by recurrent epistaxis, mucocutaneous telangiectasias, and visceral arteriovenous malformations. HHT is caused by mutation of the genes involved in the signaling pathway of transforming growth factor-β, which plays an important role in the formation of vascular endothelia1. Hepatic involvement has been reported as occurring in 30-73% of patients with HHT. However, symptomatic liver involvement is quite rare, and the representative clinical presentations of HHT in hepatic involvement are high-output heart failure, portal hypertension, nodular regenerative hyperplasia, and symptoms of biliary ischemia. Some cases of HCC in association with HHT have been reported, but are very rare. We present herein the characteristic radiologic and genetic findings of HHT that was diagnosed during the evaluation and treatment of HCC.
Abstract
This is a case report of a 68-year-old man with hepatocellular carcinoma (HCC) accompanied by hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, and hepatic vascular malformation. HHT is an autosomal dominant disorder of the fibrovascular tissue that is characterized by recurrent epistaxis, mucocutaneous telangiectasias, and visceral arteriovenous malformations. HHT is caused by mutation of the genes involved in the signaling pathway of transforming growth factor-β, which plays an important role in the formation of vascular endothelia1. Hepatic involvement has been reported as occurring in 30-73% of patients with HHT. However, symptomatic liver involvement is quite rare, and the representative clinical presentations of HHT in hepatic involvement are high-output heart failure, portal hypertension, nodular regenerative hyperplasia, and symptoms of biliary ischemia. Some cases of HCC in association with HHT have been reported, but are very rare. We present herein the characteristic radiologic and genetic findings of HHT that was diagnosed during the evaluation and treatment of HCC.
참고문헌 (18)
- Begbie ME, "Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century", Postgrad Med J, 79, pp.18~24 (2003)
- Bossler AD, "Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype", Hum Mutat, 27, pp.667~675 (2006)
- Garcia-Tsao G, "Liver involvement in hereditary hemorrhagic telangiectasia (HHT)", J Hepatol, 46, pp.499~507 (2007)
- Sadick H, "Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures", Wien Klin Wochenschr, 118, pp.72~80 (2006)
- Haitjema T, "Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment", Arch Intern Med, 156, pp.714~719 (1996)
- Buscarini E, "Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations", Liver Int, 26, pp.1040~1046 (2006)
- Larson AM, "Liver disease in hereditary hemorrhagic telangiectasia", J Clin Gastroenterol, 36, pp.149~158 (2003)
- Shovlin CL, "Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)", Am J Med Genet, 91, pp.66~67 (2000)
- Letteboer TG, "Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia", J Med Genet, 43, pp.371~377 (2006)
- Carette MF, "Imaging of hereditary hemorrhagic telangiectasia", Cardiovasc Intervent Radiol, 32, pp.745~757 (2009)
- Buscarini E, "Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease", Dig Liver Dis, 37, pp.635~645 (2005)
- Ianora AA, "Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement", Radiology, 230, pp.250~259 (2004)
- Buscarini E, "Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings", Am J Roentgenol, 163, pp.1105~1110 (1994)
- Sussman EB, "Hereditary hemorrhagic telangiectasia. A case with hepatocellular carcinoma and acquired hepatocerebral degeneration", Arch Pathol, 99, pp.95~100 (1975)
- Jameson CF, "Primary hepatocellular carcinoma in hereditary haemorrhagic telangiectasia: a case report and literature review", Histopathology, 15, pp.550~552 (1989)
- Llovet JM, "Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial", Lancet, 359, pp.1734~1739 (2002)
- Blewitt RW, "The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia", Histopathology, 42, pp.265~269 (2003)
- Scelzo C, "The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review", Transplant Proc, 39, pp.2045~2047 (2007)